Dr. Theresa Joan Buratynski, MD, MPH Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Medical Center Dr, Dhmc - Occupational Medicine, Lebanon, NH 03756 Phone: 603-650-8124 |
Elizabeth D Saich, M.D. MPH Preventive Medicine - Public Health & General Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 40 Buttrick Rd, Londonderry, NH 03053 Phone: 603-552-1400 |
William N Windler, M.D. Preventive Medicine - Occupational Medicine Medicare: Accepting Medicare Assignments Practice Location: 199 Manchester St, Manchester, NH 03103 Phone: 603-663-8718 Fax: 603-314-4554 |
Dr. Andrew Joseph Breuder, MD Preventive Medicine - Aerospace Medicine Medicare: Not Enrolled in Medicare Practice Location: 718 Smyth Rd, Va Medical Center (11), Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-626-6576 |
Dr. Richard Lee Siemens, J.D., M.D., M.P.H. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 718 Smyth Rd, V.a. Medical Center, Primary Care, Manchester, NH 03104 Phone: 603-624-4366 Fax: 603-626-6559 |
Philip J Tavares, M.D. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Accepting Medicare Assignments Practice Location: 14a Broad St, Nashua, NH 03064 Phone: 615-778-4066 |
Dr. Anne A Helker, M.D., M.P.H. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 29 Northwest Blvd, Nashua, NH 03063 Phone: 603-577-2273 |
Carol Dehaven, P.T Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: 436 Amherst St, Nashua, NH 03063 Phone: 603-889-0177 Fax: 603-889-0176 |
Dr. Donald Thomas Statuto, MD, MPH Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Not Enrolled in Medicare Practice Location: 429 Sand Hill Rd, Peterborough, NH 03458 Phone: 603-557-2608 Fax: 603-924-4094 |
Dr. David Francis Scaccia, D.O. Preventive Medicine - Preventive Medicine/Occupational Environmental Medicine Medicare: Medicare Enrolled Practice Location: 1 Navy Shipyard Rd, Portsmouth, NH 03801 Phone: 207-438-2391 |
Kevin Newell Keenan, MD Preventive Medicine - Aerospace Medicine Medicare: Medicare Enrolled Practice Location: 1 Ayres Circle, Naval Branch Health Clinic Building H-1, Portsmouth, NH 03804 Phone: 207-438-5981 Fax: 207-438-1527 |
Elaine C Holmes, MD Preventive Medicine - Occupational Medicine Medicare: Not Enrolled in Medicare Practice Location: One Ayers Circle, Bldg H 1 Naval Branch Health Clinic, Portsmouth, NH 03804 Phone: 207-438-1130 Fax: 207-438-2438 |
Dr. John Mirabello, MD Medicare: Accepting Medicare Assignments Practice Location: 21 Whitehall Rd, Suite 201, Rochester, NH 03867 Phone: 603-335-8830 Fax: 603-332-3658 |
Dawn M Richardson, M.D. Medicare: Accepting Medicare Assignments Practice Location: 311 Route 108, Somersworth, NH 03878 Phone: 603-749-2346 Fax: 603-953-0066 |
Dr. Natacha Villamia Sochat, M.D. Preventive Medicine - Public Health & General Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 358 Quaker St, Weare, NH 03281 Phone: 603-529-5907 |
News Archive
deCODE genetics (an Amgen subsidiary) and Illumina, global leaders in analyzing and understanding the human genome, together with scientists from the National Hospital of Iceland and the University of Iceland reported today in the journal Nature the identification of a rare nonsense mutation that confers high risk of osteoporosis and osteoporosis related traits.
John Wiley & Sons, Inc., today announced the launch of Molecular Genetics & Genomic Medicine (MGGM), a new Wiley Open Access journal. Under the leadership of Editor-in-Chief Dr. Maximilian Muenke, the journal will provide rapid dissemination of high-quality research in all areas of human, medical and molecular genetics.
A combination of two types of blood pressure-lowering drugs, an angiotensin-converting enzyme inhibitor (ACEI) plus an angiotensin-receptor blocker (ARB), added to enzyme replacement therapy (ERT) with agalsidase-beta (Fabrazyme, Genzyme Corporation, Cambridge, MA) is the first treatment shown to stop progressive loss of kidney function in patients with severe kidney involvement due to the rare genetic disorder Fabry disease, reports a study in the September Journal of the American Society of Nephrology.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the initiation of a confirmatory Phase 3 clinical trial to further evaluate otelixizumab in autoimmune new-onset type 1 diabetes. The confirmatory Phase 3 clinical trial is called DEFEND-2 (Durable-Response Therapy Evaluation For Early or New-Onset Type 1 Diabetes) and immediately follows successful completion of enrollment in the initial Phase 3 clinical trial, DEFEND-1, with results from DEFEND-1 expected in the first half of 2011.
› Verified 6 days ago